secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001558370-23-000123
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio reports ~$190M cash as of Dec 31, 2022; runway into H1 2025
-----------------------------------------------------------------------

- Preliminary unaudited cash, equivalents and marketable securities of ~$190M at Dec 31, 2022.
- Cash runway expected to fund operating expenses and capex into first half of 2025.
- Update provided in January 9, 2023 corporate presentation; figures subject to audit.
- No other financial results or guidance changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000155837023000123/0001558370-23-000123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000155837023000123/pasg-20230109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-000123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer